Asymmetric Cross-Mannich Reaction
1987 1997
Chiralpak AD, hexanes/iPrOH=90:10, flow rate 0.5 mLminÀ1
254 nm): major isomer: tR =43.56 min; minor isomer: tR =37.88 min.
,
l=
[M+H]+ ; HPLC (Daicel Chiralpak AD, hexanes/iPrOH=98:2, flow rate
0.5 mLminÀ1, l=254 nm): major isomer: tR =154.7 min; minor isomer:
tR =94.3 min.
(2S,3S)-2-Methyl-3-(4-methoxyphenylamino)-3-pentan-1-ol (14): [a]D =+
8.5 (c=1 in MeOH); 1H NMR (CD3OD): d=0.92 (t, J=6.9 Hz, 3H),
0.95 (d, J=7.7 Hz, 3H), 1.52 (m, 2H), 1.87 (m, 1H), 3.50 (dd, 1H), 3.66
(dd, 1H), 3.68 (s, 3H; OMe), 6.70 (d, J=8.8 Hz, 2H), 6.81 ppm (d, J=
8.8 Hz, 2H); 13C NMR: d=11.9, 12.3, 26.7, 40.0, 56.4, 58.8, 66.3, 115.9,
116.0, 145.3, 153.0 ppm; HR-MS: m/z calcd for C13H21NO2: 224.1645;
General procedure for the direct catalytic synthesis of b-formyl amino
acid derivatives
Ethyl (2S,3S)-3-formyl-2-(4-methoxyphenylamino)butanoate (24): Ethyl
glyoxylate (2.5 mmol) and p-anisidine (2.8 mmol) were stirred in the
presence of
a catalytic amount of (S)-proline (10 mol%) in DMF
found: 224.1645 [M+H]+
; HPLC (Daicel Chiralpak AD, hexanes/
(2.5 mL) for 30 minutes at room temperature. Next, the temperature was
decreased to 48C, followed by addition of the propanal (5 mmol). After
stirring for 20 24 h, the reaction was quenched by addition of aqueous
NH4Cl solution, followed by extraction with EtOAc. The combined or-
ganic layers were dried (MgSO4), filtered, and concentrated. Purification
of the residue by flash column chromatography (pentanes/ethyl acetate=
5:1) afforded the corresponding b-formyl amino acid derivative 24
(0.38 g, 65%): ꢀ1.5:1 mixture of diastereoisomers, * denotes the anti dia-
iPrOH=99:1, flow rate 1.0 mLminÀ1, l=254 nm): major isomer: tR =
8.09 min; minor isomer: tR =12.18 min.
(2S,3S)-2-Methyl-3-(phenylamino)-3-(2-pyridinyl)propan-1-ol (15): [a]D =
À34.1 (c=1.6 in MeOH); 1H NMR (CD3OD): d=0.96 (d, J=7.0 Hz,
3H), 2.21 (m, 1H), 3.41 (dd, 1H), 3.59 (dd, 1H), 4.60 (d, J=5.9 Hz, 1H),
6.54 (m, 2H), 7.18 (d, 2H), 7.42 (m, 1H), 7.63 (m, 1H), 8.47 ppm (m,
1H); 13C NMR: d=12.8, 42.7, 61.9, 65.9, 114.6, 118.2, 123.6, 130.0, 138.6,
143.6, 149.4, 149.7, 164.3 ppm; HR-MS: m/z calcd for C15H18N2O:
243.1497; found: 243.1495 [M+H]+ ; HPLC (Daicel Chiralpak AD, hex-
anes/iPrOH=90:10, flow rate 0.5 mLminÀ1, l=254 nm): major isomer:
tR =28.87 min; minor isomer: tR =25.34 min;.
1
stereomer. H NMR (CDCl3): d=1.10 1.40 (m, 12H), 2.87 (m, 2H), 3.73
(brs, 3H, 3H*; OMe), 3.91 (d, 1H, 1H*), 4.16 (m, 2H, 2H*), 4.38 (d,
J=6.6 Hz, 1H*), 4.49 (d, J=3.4 Hz, 1H), 6.67 (m, 2H, 2H*), 6.77 (m,
2H, 2H*), 9.72 ppm (brs, 1H, 1H*); 13C NMR: d=9.0, 9.8, 14.1, 14.1,
48.1, 48.4, 55.5, 55.6, 58.4, 58.6, 61.5, 61.6, 114.7, 114.8, 115.6, 116.3, 140.1,
140.4, 153.1, 153.4, 171.7, 172.3, 201.7, 201.8 ppm; HR-MS: m/z calcd for
C14H19NO4Na: 265.1309; found: 265.1316 [M+Na]+ ; HPLC (Daicel Chir-
(2S,3S)-2-Methyl-3-(4-bromophenylamino)-3-(2-pyridinyl)propan-1-ol
(16): [a]D =À29.1 (c=2.1 in MeOH); 1H NMR (CD3OD): d=0.97 (d,
J=7.0 Hz, 3H), 2.19 (m, 1H), 3.40 (m, 1H), 3.53 (m, 1H), 4.61 (d, J=
5.9 Hz, 1H), 6.49 (m, 2H), 7.10 (m, 2H), 7.21 (m, 1H), 7.42 (m, 1H),
7.67 (m, 1H), 8.48 ppm (m, 1H); 13C NMR: d=12.7, 42.7, 61.9, 65.7,
114.6, 118.1, 123.5, 123.7, 130.0, 138.5, 149.7, 149.7 d, 164.3 ppm; HR-MS:
m/z calcd for C15H17BrN2O: 321.0602; found: 321.060 [M+H]+ ; HPLC
alpak AS, hexanes/iPrOH=99:1, flow rate 1.0 mLminÀ1
, l=254 nm):
major isomer: tR =18.82 min, major isomer*: tR =20.12 min, minor
isomer: tR =23.11 min, minor isomer: tR =27.01 min.
(2S,3S)-3-Hydroxymethyl-2-(4-methoxyphenylamino)-4-methylpentan-1-
ol (30): Ethyl glyoxylate (2.5 mmol) and p-anisidine (2.8 mmol) were stir-
red in the presence of a catalytic amount of (S)-proline (10 mol%) in
DMF (2.5 mL) for 30 minutes at room temperature. Next, the tempera-
ture was decreased to 48C, followed by addition of isovaleraldehyde
(5 mmol). After stirring for 20 h, the reaction mixture was diluted with
THF (30 mL), and LiAlH4 (50 mL, 1m solution in THF) was added. The
reaction mixture was allowed to reach room temperature and stirred for
1 h. The mixture was cooled and quenched by careful addition of aque-
ous NH4Cl solution, followed by 3m HCl, and extraction with Et2O. The
combined organic layers were dried (MgSO4), filtered, and concentrated.
Purification of the residue by flash column chromatography (hexanes/
ethyl acetate 1:5) afforded diol 30 as a pale yellow oil (0.7 g, 85%): 1H
NMR (CDCl3): d=0.93 (d, J=7.9 Hz, 3H), 1.02 (d, J=7.9 Hz, 3H), 1.55
(m, 1H), 1.92 (m, 1H), 3.55 (m, 1H), 3.63 (m, 1H), 3.71 3.3.83 (m, 6H),
6.58 (d, J=8.8 Hz, 2H), 6.76 ppm (d, J=8.8 Hz, 2H); 13C NMR: 20.1,
21.3, 25.9, 47.5, 55.2, 55.7, 59.1, 60.8, 115.0, 115.2, 141.1, 152.1 ppm; HR-
(Daicel Chiralpak AD, hexanes/iPrOH=90:10, flow rate 0.5 mLminÀ1
l=254 nm): major isomer: tR =29.59 min; minor isomer: tR =39.57 min.
,
(2S,3S)-2-Methyl-3-(4-iodophenylamino)-3-(2-pyridinyl)propan-1-ol (18):
[a]D =À31.2 (c=0.6 in MeOH); 1H NMR (CD3OD): d=0.99 (d, J=
7.0 Hz, 3H), 2.21 (m, 1H), 3.41 3.59 (m, 2H), 4.58 (d, J=5.1 Hz, 1H),
6.40 (m, 2H), 7.26 (m, 3H), 7.45 (m, 1H), 7.75 (m, 1H), 8.52 ppm (m,
1H); 13C NMR: d=9.9, 39.8, 58.8, 62.8, 114.0, 120.7, 120.8, 135.7, 135.8,
146.4, 146.8, 147.0 ppm; HR-MS: m/z calcd for C15H17IN2O: 350.0753;
found: 350.0751 [M+H]+
; HPLC (Daicel Chiralpak AD, hexanes/
iPrOH=90:10, flow rate 0.5 mLminÀ1, l=254 nm): major isomer: tR =
38.22 min; minor isomer: tR =29.18 min.
(1S,2S)-1-(4-Methoxyphenylamino)-1-(2-pyridyl)-2-hydroxymethylbutane
(21): ꢀ2:1 mixture of diastereoisomers, * denotes the anti diastereomer;
1H NMR (CD3OD): d=0.88 (t, J=7.0 Hz, 1.5H*), 0.90 (t, J=7.0 Hz,
3H), 1.39 1.61 (m, 2H, 1H*), 1.85 1.98 (m, 1H, 1H*), 3.51 (dd, 1H*),
3.53 (dd, 2H), 3.61 (s, 3H, 1.5H*; OMe), 4.34 (d, J=7.0 Hz, 1H*), 4.59
(d, J=4.0 Hz, 1H), 6.48 (dd, 2H, 1H*), 6.61 (dd, 2H, 1H*), 7.19 (m, 1H,
0.5H*), 7.42 (m, 1H, 0.5H*), 7.67 (m, 1H, 0.5H*), 8.47 ppm (m, 1H,
0.5H*); 13C NMR: d=12.2, 12.4, 20.4, 22.4, 49.8, 56.3, 62.4, 63.0, 115.5,
115.8, 115.9, 116.0, 116.1, 123.5, 123.6, 124.0, 124.1, 138.4, 138.5, 143.6,
149.7, 153.5, 164.2, 164.5 ppm; HR-MS: m/z calcd for C17H22N2O2:
272.1645; found: 2721645 [M+H]+ ; HPLC (Daicel Chiralpak AD, hex-
anes/iPrOH=98:2, flow rate 0.5 mLminÀ1, l=254 nm): major isomer:
tR =59.35 min; minor isomer: tR =46.47 min; major isomer*: tR =
61.17 min; minor isomer*: tR =59.35 min.
MS: m/z calcd for C14H32NO3: 254.1751; found: 254.1752 [M+H]+
;
HPLC (Daicel Chiralpak AS, hexane/iPrOH=99:1, flow rate
1.0 mLminÀ1, l=254 nm): tR (major)=23.12 min; tR (minor)=26.64 min.
Ethyl (2S,3S)-3-[(R)-cyanohydroxymethyl)-2-(4-methoxyphenylamino]-4-
methylpentanoate (31): Ethyl glyoxylate (2.5 mmol) and p-anisidine
(2.8 mmol) were stirred in the presence of a catalytic amount of (S)-pro-
line (10 mol%) in DMF (2.5 mL) for 30 minutes at room temperature.
Next, the temperature was decreased to 48C, followed by addition of iso-
valeraldehyde (5 mmol). After stirring for 20 h, the reaction mixture was
diluted with THF (7.5 mL) and the temperature was decreased to
À758C. Next, Et2AlCN (1m solution in toluene, 10 mmol) was added,
and the solution was stirred for 2.5 h. The mixture was quenched by addi-
tion of 1m NaHCO3 and extracted with EtOAc. The combined organic
layers were dried (MgSO4), filtered, and concentrated. Purification of the
residue by flash column chromatography (pentanes/ethyl acetate=4:1)
afforded cyanohydrin 31 as a clear oil (0.52 g, 66%): [a]D =À13.3 (c=2.5
in CH2Cl2); 1H NMR (CDCl3): d=1.10 (d, J=5.5 Hz, 3H), 1.16 (d, J=
5.5 Hz, 3H), 1.28 (t, 3H), 2.18 (brs, 2H), 3.74 (s, 3H; OMe), 4.22 (q,
2H), 4.39 (d, J=6.3 Hz, 1H), 4.87 (brs, 1H), 6.70 (d, J=8.8 Hz, 2H),
6.79 ppm (d, J=8.8 Hz, 2H); 13C NMR: 13.9, 20.7, 21.4, 26.3, 50.7, 55.6,
57.8, 61.2, 61.6, 114.8, 116.4, 119.2, 139.9, 153.4, 173.4 ppm; HR-MS: m/z
calcd for C14H32NO3: 321.1809; found: 321.1811 [M+H]+ ; HPLC (Daicel
(1S,2S)-1-(4-Methoxyphenylamino)-1-(4-nitrophenyl)-2-hydroxymethyl-
heptane (22): [a]D =À24.7 (c=0.2 in MeOH); 1H NMR (CD3OD): d=
0.83 (t, J=7.0 Hz, 3H), 1.22 1.55 (m, 8H), 2.08 (m, 1H), 3.54 (d, J=
3.3 Hz, 1H), 3.68 (s, 3H; OMe), 3.73 (d, J=3.3 Hz, 1H), 4.71 (d, J=
3.3 Hz, 1H), 6.48 (d, J=8.8 Hz, 2H), 6.68 (d, J=8.8 Hz, 2H), 7.51 (d, J=
8.8 Hz, 2H), 8.17 ppm (d, J=8.8 Hz, 2H); 13C NMR: d=14.4, 22.9, 27.8,
29.7, 46.4, 56.1, 63.9, 96.6, 115.3, 124.1, 128.7, 147.5 ppm; HR-MS: m/z
calcd for C21H28N2O4: 373.2122; found: 373.2120 [M+H]+ ; HPLC (Daicel
Chiralpak AD, hexanes/iPrOH=90:10, flow rate 1.0 mLminÀ1
254 nm): major isomer: tR =17.79 min; minor isomer: tR =7.43 min.
, l=
(1S,2S)-1-(4-Methoxyphenylamino)-1-(2-pyridyl)-2-hydroxymethylhep-
tane (23): [a]D =À33.9 (c=0.3 in MeOH); 1H NMR (CD3OD): d=0.82
(t, J=7.0 Hz, 3H), 1.22 1.55 (m, 8H), 2.08 (m, 1H), 3.54 (d, J=3.3 Hz,
1H), 3.59 (d, J=3.3 Hz, 1H), 3.59 (s, 3H; OMe), 4.64 (d, J=3.3 Hz, 1H),
6.51 (d, J=8.8 Hz, 2H), 6.62 (d, J=8.8 Hz, 2H) 7.16 (m, 1H), 7.41 (m,
1H), 7.65 (m, 1H), 8.46 ppm (m, 1H); 13C NMR: d=14.6, 23.7, 27.3,
28.5, 33.2, 48.8, 56.3, 62.5, 63.5, 123.5, 124.1, 138.4, 143.6, 149.7, 153.4,
164.2 ppm; HR-MS: m/z calcd for C20H28N2O4: 373.2122; found: 373.2120
Chiralcel OD-H, hexane/iPrOH 98:2, flow rate 1.0 mLminÀ1
254 nm): tR (major) =8.32 min; tR (minor) =12.59 min.
, l=
Synthesis of (2S,3S)-2-methyl-3-(4-methoxyphenylamino)-3-phenylpro-
pan-1-ol and (2R,3S)-2-methyl-3-(4-methoxyphenylamino)-3-phenylpro-
pan-1-ol: A diastereomeric mixture (syn/anti 0.9:1) of methyl (3S)-2-
1995
Chem. Eur. J. 2004, 10, 1987 1997
¹ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim